LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis

References

• Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42(2):211–217.
   PubMed Web of Science ®Google Scholar
• Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107(3):230–236.
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.
   Google Scholar
• Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403–2414.
   PubMed Web of Science ®Google Scholar
• Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203.
   PubMed Web of Science ®Google Scholar
• Zou T, Wang PL, Gao Y, et al. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion. Cancer Biomark. 2019;25(2):133–139.
   PubMed Web of Science ®Google Scholar
• Lei GL, Niu Y, Cheng S-J, et al. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol. 2021;27(20):2586–2602.
   PubMed Web of Science ®Google Scholar
• Xu W, Xu Q, Kuang D, et al. Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2. Mol Med Rep. 2019;20(3):2591–2596.
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhang J, Fan L, et al. Long noncoding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) predicts poor prognosis and sorafenib resistance in hepatocellular carcinoma. Med Sci Monit. 2019;25:2079–2086.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y. Long noncoding RNA (lncRNA) MIR22HG suppresses gastric cancer progression through attenuating NOTCH2 signaling. Med Sci Monit. 2019;25:656–665.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Y, Zhang Z, et al. Long non-coding RNA NRON promotes tumor proliferation by regulating ALKBH5 and nanog in gastric cancer. J Cancer. 2021;12(22):6861–6872.
   PubMed Web of Science ®Google Scholar
• Zhao W, Jin Y, Wu P, et al. LINC00355 induces gastric cancer proliferation and invasion through promoting ubiquitination of P53. Cell Death Discov. 2020;6(1):99.
   PubMed Web of Science ®Google Scholar
• Ping J, Huang S, Wu J, et al. Association between lincRNA expression and overall survival for patients with triple-negative breast cancer. Breast Cancer Res Treat. 2021;186(3):769–777.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao Z, Miao F, et al. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation. Cancer Gene Ther. 2021;28(5):471–485.
   PubMed Web of Science ®Google Scholar
• Liu S, Xie X, Lei H, et al. Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 2019;25:1679–1693.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zheng J, Liu L. The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer. Cancer Cell Int. 2019;19(1):304.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lei X, Gao C, et al. MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6. J Biosci. 2019;44(6). DOI:10.1007/s12038-019-9952-9.
   Web of Science ®Google Scholar
• Luo J, Wang K, Yeh S, et al. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun. 2019;10(1):2571.
   PubMedGoogle Scholar
• Xue K, Li J, Nan S, et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci. 2019;231:116459.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79(1):351–379.
   PubMed Web of Science ®Google Scholar
• Liu M, Wu H, Liu Y, et al. MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1. Sci Prog. 2021;104(2):368504211009379.
   PubMedGoogle Scholar
• Cai L, Chen -J-J, Deng F-M, et al. MiR-326 regulates the proliferation and apoptosis of endometrial cancer by targeting Bcl-2. J Obstet Gynaecol Res. 2021;47(2):621–630.
   PubMed Web of Science ®Google Scholar
• Zhang\ J, Wei X, Zhang W, et al. MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways. Eur J Pharmacol. 2020;872:172941.
   PubMed Web of Science ®Google Scholar
• Mo WL, Jiang JT, Zhang L, et al. Circular RNA HSA_circ_0000467 promotes the development of gastric cancer by competitively binding to MicroRNA miR-326-3p. Biomed Res Int. 2020;2020:4030826.
   PubMed Web of Science ®Google Scholar
• Song W, Qian Y, Zhang M-H, et al. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(6):3049–3061.
   PubMed Web of Science ®Google Scholar
• Li Y, Gao Y, Xu Y, et al. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer. Growth Factors. 2015;33(4):267–274.
   PubMed Web of Science ®Google Scholar
• Ji S, Zhang B, Kong Y, et al. miR-326 inhibits gastric cancer cell growth through downregulating NOB1. Oncol Res. 2017;25(6):853–861.
   PubMed Web of Science ®Google Scholar
• Deng M, Tong R, Zhang Z, et al. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma. Cancer Cell Int. 2021;21(1):535.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yin B, Wang B, et al. MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3. Oncol Res. 2013;21(3):145–154.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang L, Zhou X, et al. OSCC exosomes regulate miR-210-3p targeting EFNA3 to promote oral cancer angiogenesis through the PI3K/AKT pathway. Biomed Res Int. 2020;2020:2125656.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang D-H, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718.
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113–1121.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang Q, Lu L, et al. Long noncoding RNA DLGAP1-AS1 promotes the aggressive behavior of gastric cancer by acting as a ceRNA for microRNA-628-5p and raising astrocyte elevated gene 1 expression. Cancer Manag Res. 2020;12:2947–2960.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu H, Yang H, et al. The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer. Onco Targets Ther. 2017;10:3353–3362.
   PubMed Web of Science ®Google Scholar
• Cao Y, Xiong J-B, Zhang G-Y, et al. Long noncoding RNA UCA1 regulates PRL-3 expression by sponging MicroRNA-495 to promote the progression of gastric cancer. Mol Ther Nucleic Acids. 2020;19:853–864.
   PubMedGoogle Scholar